Leidos (NYSE:LDOS) Price Target Cut to $199.00 by Analysts at Wells Fargo & Company

Leidos (NYSE:LDOS) had its target price reduced by equities research analysts at Wells Fargo & Company from $205.00 to $199.00 in a report released on Wednesday,Benzinga reports. The firm presently has an “overweight” rating on the aerospace company’s stock. Wells Fargo & Company‘s target price would suggest a potential upside of 37.65% from the company’s previous close.

A number of other brokerages have also commented on LDOS. JPMorgan Chase & Co. upped their price target on Leidos from $175.00 to $185.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Barclays upped their target price on shares of Leidos from $165.00 to $210.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Royal Bank of Canada raised their price target on shares of Leidos from $145.00 to $180.00 and gave the stock a “sector perform” rating in a research report on Wednesday, October 30th. Citigroup upped their price objective on shares of Leidos from $194.00 to $220.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. Finally, Robert W. Baird lifted their target price on Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Five analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $179.07.

Leidos Stock Performance

Shares of NYSE:LDOS traded down $2.73 during trading on Wednesday, reaching $144.57. The stock had a trading volume of 190,705 shares, compared to its average volume of 892,410. The stock has a fifty day simple moving average of $163.06 and a two-hundred day simple moving average of $157.84. The company has a quick ratio of 1.15, a current ratio of 1.23 and a debt-to-equity ratio of 0.87. Leidos has a 52 week low of $107.73 and a 52 week high of $202.90. The firm has a market capitalization of $19.29 billion, a price-to-earnings ratio of 16.47, a P/E/G ratio of 1.04 and a beta of 0.66.

Leidos (NYSE:LDOS) last announced its earnings results on Tuesday, October 29th. The aerospace company reported $2.93 EPS for the quarter, topping the consensus estimate of $1.96 by $0.97. The firm had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $4.06 billion. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The business’s quarterly revenue was up 6.9% on a year-over-year basis. During the same quarter last year, the firm posted $2.03 EPS. As a group, analysts anticipate that Leidos will post 9.89 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Surya N. Mohapatra sold 2,748 shares of the stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $194.97, for a total transaction of $535,777.56. Following the sale, the director now directly owns 20,001 shares in the company, valued at $3,899,594.97. This represents a 12.08 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of Leidos stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $184.94, for a total value of $193,632.18. Following the completion of the transaction, the director now owns 6,408 shares of the company’s stock, valued at approximately $1,185,095.52. The trade was a 14.04 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.96% of the company’s stock.

Institutional Investors Weigh In On Leidos

A number of hedge funds have recently added to or reduced their stakes in the stock. Ballentine Partners LLC grew its stake in shares of Leidos by 3.5% during the third quarter. Ballentine Partners LLC now owns 1,822 shares of the aerospace company’s stock valued at $297,000 after purchasing an additional 62 shares during the last quarter. Asahi Life Asset Management CO. LTD. increased its stake in shares of Leidos by 3.2% in the 3rd quarter. Asahi Life Asset Management CO. LTD. now owns 2,280 shares of the aerospace company’s stock valued at $372,000 after buying an additional 70 shares during the period. Somerset Trust Co raised its position in shares of Leidos by 3.5% during the third quarter. Somerset Trust Co now owns 2,429 shares of the aerospace company’s stock worth $396,000 after acquiring an additional 83 shares during the last quarter. Apella Capital LLC lifted its stake in shares of Leidos by 0.8% during the third quarter. Apella Capital LLC now owns 11,366 shares of the aerospace company’s stock valued at $1,878,000 after acquiring an additional 89 shares during the period. Finally, Foundations Investment Advisors LLC boosted its holdings in Leidos by 6.3% in the third quarter. Foundations Investment Advisors LLC now owns 1,679 shares of the aerospace company’s stock valued at $274,000 after acquiring an additional 99 shares during the last quarter. Institutional investors own 76.12% of the company’s stock.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.